# Sitagliptin + Metformin Compared to Metformin Monotherapy and Placebo in Women With a Recent GDM

> **NCT01856907** · PHASE4 · COMPLETED · sponsor: **Woman's** · enrollment: 36 (actual)

## Conditions studied

- Disorder of Glucose Regulation

## Interventions

- **DRUG:** Sitagliptin-Metformin
- **DRUG:** Metformin
- **DRUG:** Placebo pill

## Key facts

- **NCT ID:** NCT01856907
- **Lead sponsor:** Woman's
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09-28
- **Primary completion:** 2017-09-05
- **Final completion:** 2017-09-28
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2018-01-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01856907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01856907, "Sitagliptin + Metformin Compared to Metformin Monotherapy and Placebo in Women With a Recent GDM". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT01856907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*